scholarly journals Exome sequencing identifies a nonsense mutation in Fam46a associated with bone abnormalities in a new mouse model for skeletal dysplasia

2016 ◽  
Vol 27 (3-4) ◽  
pp. 111-121 ◽  
Author(s):  
Susanne Diener ◽  
Sieglinde Bayer ◽  
Sibylle Sabrautzki ◽  
Thomas Wieland ◽  
Birgit Mentrup ◽  
...  
2007 ◽  
Vol 104 (39) ◽  
pp. 15394-15399 ◽  
Author(s):  
C. Yang ◽  
J. Feng ◽  
W. Song ◽  
J. Wang ◽  
B. Tsai ◽  
...  

2017 ◽  
Vol 57 (1) ◽  
pp. 4-7 ◽  
Author(s):  
Bo Wang ◽  
Niu Li ◽  
Juan Geng ◽  
Zhigang Wang ◽  
Qihua Fu ◽  
...  

2020 ◽  
Vol 201 ◽  
pp. 108274
Author(s):  
Daniel K. Crawford ◽  
Phillip Vanlandingham ◽  
Susan Schneider ◽  
Matthew M. Goddeeris

2020 ◽  
Vol 40 (5) ◽  
pp. 577-584 ◽  
Author(s):  
Jin Han ◽  
Yan‐Dong Yang ◽  
Yi He ◽  
Wen‐Jie Liu ◽  
Li Zhen ◽  
...  

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Lara Pemberton ◽  
Robert Barker ◽  
Anna Cockell ◽  
Vijaya Ramachandran ◽  
Andrea Haworth ◽  
...  

Abstract Background Osteocraniostenosis (OCS) is a rare genetic disorder characterised by premature closure of cranial sutures, gracile bones and perinatal lethality. Previously, diagnosis has only been possible postnatally on clinical and radiological features. This study describes the first prenatal diagnosis of OCS. Case presentation In this case prenatal ultrasound images were suggestive of a serious but non-lethal skeletal dysplasia. Due to the uncertain prognosis the parents were offered Whole Exome Sequencing (WES), which identified a specific gene mutation in the FAMIIIa gene. This mutation had previously been detected in two cases and was lethal in both perinatally. This established the diagnosis, a clear prognosis and allowed informed parental choice regarding ongoing pregnancy management. Conclusions This case report supports the use of targeted WES prenatally to confirm the underlying cause and prognosis of sonographically suspected abnormalities.


PLoS ONE ◽  
2016 ◽  
Vol 11 (6) ◽  
pp. e0156981 ◽  
Author(s):  
Xiaoru Xia ◽  
Caijun Dai ◽  
Xiaochun Zhu ◽  
Qiumei Liao ◽  
Xu Luo ◽  
...  

2020 ◽  
Author(s):  
Harvey Perez ◽  
May F. Abdallah ◽  
Jose I. Chavira ◽  
Martin T. Egeland ◽  
Karen L. Vo ◽  
...  

AbstractAtaxia Telangiectasia (A-T) is caused by null mutations in the genome stability gene, ATM (A-T mutated). In mice, similar null mutations do not replicate A-T’s characteristic severe ataxia with associated cerebellar dysfunction and atrophy. By increasing genotoxic stress, through the insertion of null mutations in the Atm (nonsense) and related Aptx (knockout) genes, we have generated a novel A-T mouse that first develops mild ataxia, associated with abnormal Purkinje neuron (PN) activity and decreased size, progressing to severe ataxia correlated with further reduced PN activity as well as PN loss and overall cerebellar atrophy. These mice also exhibit high incidences of cancer and immune abnormalities that are all hallmarks of the human disorder. Enabled by the insertion of a clinically relevant nonsense mutation in Atm, we demonstrate that small molecule readthrough (SMRT) compounds can restore ATM production, indicating their potential as a future A-T therapeutic.


2017 ◽  
Vol 48 (S 01) ◽  
pp. S1-S45
Author(s):  
J. Johannsen ◽  
J. Heinemeyer ◽  
M. Hempel ◽  
D. Lessel ◽  
S. Mueller-Stoever ◽  
...  

2020 ◽  
Vol 11 (4) ◽  
pp. 228-231 ◽  
Author(s):  
Ozlem Gorukmez ◽  
Orhan Gorukmez

Male infertility is multifactorial and presents with heterogeneous phenotypic features. Genetic factors are responsible for up to 15% of the male infertility cases. Loss of the <i>Cstf2t</i> gene in male mice results in infertility. No disease-associated mutations have been described for this gene in infertile men. Here, we report a patient diagnosed with infertility in whom a homozygous nonsense mutation in the <i>CSTF2T</i> gene was detected by clinical exome sequencing. This case is the first description of an infertile patient who has a homozygous <i>CSTF2T</i> mutation.


Sign in / Sign up

Export Citation Format

Share Document